OZ FUSION
← Return to Protocol LibraryHULK PROTOCOL
HULK PROTOCOL
Couldn't load pickup availability
COMPOUNDS INCLUDED
1 x 1mg vial
2 x 10mg vial
IGF-1LR3
CJC-1295 (NO DAC)
IPAMORELIN
A structured breakdown of the compounds within the HULK protocol, designed around anabolic signalling, growth support, and a more aggressive mass-focused performance framework.
IGF-1 LR3
IGF-1 LR3 is a synthetic peptide analogue referenced in research for its association with anabolic signalling, nutrient partitioning models, and growth-oriented performance frameworks. Within the HULK protocol, it provides the dominant size and development component, anchoring the protocol in aggressive progression and amplified output.
IPAMORELIN
Ipamorelin is a selective peptide studied for its association with pulsatile growth hormone release, recovery optimisation, and tissue-support models. In the HULK protocol, it reinforces the anabolic environment by supporting a cleaner pulse-based growth hormone response within a broader mass-focused framework.
CJC-1295 (NO DAC)
CJC-1295 (no DAC) is a synthetic peptide analogue referenced in research for its association with growth hormone signalling, recovery support, and performance-focused restoration pathways. Within the HULK protocol, it broadens the signalling framework around Ipamorelin, helping create a stronger and more complete environment for progression, output, and recovery continuity.
The HULK protocol is structured as a three-part growth system. IGF-1 LR3 provides the dominant anabolic and development-focused driver, Ipamorelin adds a selective pulse-based growth hormone support layer, and CJC-1259 (no DAC) broadens the signalling environment to reinforce progression and recovery continuity. Together, they form a more complete framework built around size, output, and amplified performance potential.